Frontier Clinical Research

Frontier Clinical Research is attending SOS Save Our Sites 2025 in Oklahoma City, a dynamic two-day event designed exclusively for the unsung heroes of the clinical research industry—our frontline workers, such as Clinical Research Coordinators (CRCs) and site staff.

Heroes walk among us! During a recent local community event, a young man’s quick thinking and CPR training helped save a woman's life when she had a medical emergency. Tristin Szabo, who is a E.R. Nurse at Uniontown Hospital, attended the event as a guest with Frontier Clinical Research. He acted with no hesitation and quickly performed CPR on this woman at the Fairchance Exchange Club Dinner this past Saturday night. Dr. Goisse from Montgomery Medical who was also attending this event, was called to the scene for further assessment. This moment highlights the importance of CPR training and knowing how to act in critical situations. Montgomery Medical and Frontier Clinical Research want to extend their deepest thanks to this young hero for stepping up and making a difference when it mattered most. This situation is an example to show how important it is to have CPR training. CPR training is not just for healthcare workers and emergency responders, it can be used by anyone. #CPRTraining #CommunityHeroes #ThankYou

We had a fantastic experience attending the Society for Clinical Research Sites (SCRS) Annual Summit! This event serves as a valuable hub for bringing together sites, sponsors, CRO executives, and regulators to explore innovations and best practices in clinical research. It was an incredible opportunity for networking, collaborating in workshops, brainstorming in ideation sessions, and forming strategic partnerships to advance the future of clinical research. #ClinicalResearch

Our Smithfield site had the pleasure of participating in a fantastic community event hosted by South Union Township! With perfect weather and over 1,500 kids attending, it was a fun-filled day of trick-or-treating and smiles all around! ????#CommunitySupport #Halloweenfun

Great news! We’re excited to announce that TREMFYA is now FDA approved to treat UC! Clinical trials were conducted at our Uniontown site, and we are incredibly grateful to all the participants who contributed to making this treatment a reality to help improve the lives of many. Learn more about this exciting development by checking out the article link in the comments! #FDAApproved #ClinicalResearch #ThankYouParticipants #NewTreatment

Last week, we had the pleasure of donating school supplies to local schools during the Fayette Chamber of Commerce After Hours event at the Hilton Garden Inn. It was great to see so many representatives from local businesses come together to network and support our schools. We're thrilled to be part of a community that steps up to help out in such a meaningful way!

Check out this article we found worth reading! Frontier Clinical Research participated in a clinical trial for this skin cancer device to hep clinicians effectively detect skin cancer with the help of AI. Learn more by clicking out the link in our comment section. #ClinicalTrials #AIAdvancements

Another successful Lunch and Learn with Montgomery Medical's providers and staff! We're committed to keeping everyone informed about newly enrolling clinical trials for various health conditions. These studies provide patients with access to alternative potential treatment options while contributing to the discovery of new therapies for future generations. #PartnershipForHealth

A more pleasant way to screen for colon cancer with a Shield blood test! An innovation in colorectal cancer screening! A newly FDA-approved blood-based screening test for #ColorectalCancer has potential to help overcome barriers that have limited screening rates in the past. Frontier Clinical Research is proud to have shared the support of this approval from our sites! Learn more: https://lnkd.in/eukRmVRW

Now FDA-Approved: An innovation in colorectal cancer screening! A newly FDA-approved blood-based screening test for #ColorectalCancer has potential to help overcome barriers that have limited screening rates in the past. The ECLIPSE study supporting this approval was conducted in part at our site and we are proud to have contributed to this important milestone! Learn more: https://lnkd.in/eukRmVRW